SELLAS Life Sciences Group, Inc.

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

SLS

organization

SIC: 2834

SEC Insider

$42.1M

578 transactions

Summary

SELLAS Life Sciences Group, Inc. (SLS) is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $326KSales: $36.9M53 insiders

Date	Insider	Type	Value
2025-12-03	Stergiou Angelos M.(President and CEO)	J	$281K
2025-11-19	Kalin Katherine Bach	Buy	$101K
2025-12-03	CICIC DRAGAN(SVP, Chief Development Officer)	J	$96K
2025-12-03	Burns John Thomas(CFO)	J	$88K
2025-05-22	Kalin Katherine Bach	Buy	$36K
2025-05-30	Wasman Jane	Buy	$34K
2025-06-12	VAN NOSTRAND ROBERT L	Buy	$15K
2026-06-16	Stergiou Angelos M.(President and CEO)	A	$0
2026-01-07	Wasman Jane	A	$0
2026-01-07	Kalin Katherine Bach	A	$0
2026-01-07	Burns John Thomas(CFO)	A	$0
2026-01-07	CICIC DRAGAN(SVP, Chief Development Officer)	A	$0
2026-01-07	SCHEINBERG DAVID A	A	$0
2026-01-07	VAN NOSTRAND ROBERT L	A	$0
2026-01-07	Varian John	A	$0
2025-01-10	CICIC DRAGAN(SVP, Chief Development Officer)	A	$0
2025-01-10	CICIC DRAGAN(SVP, Chief Development Officer)	A	$0
2025-01-10	CICIC DRAGAN(SVP, Chief Development Officer)	A	$0
2025-01-10	Varian John	A	$0
2025-01-10	Varian John	A	$0

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

SELLAS Life Sciences Group, Inc. — Contributions, Lobbying & Contracts | Poliscope